info@marketresearchfuture.com   📞  +1 (855) 661-4441(US)   📞  +44 1720 412 167(UK)
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Autoimmune Disease Diagnostics Companies

Autoimmune Disease Diagnostics companies play a vital role in early disease detection. Specializing in research, development, and distribution, they provide cutting-edge diagnostic tools, contributing to timely and accurate identification of autoimmune diseases, crucial for effective management and treatment.

Autoimmune Disease Diagnostics Market

 


Latest Autoimmune Disease Diagnostics Companies Updates:


Mayo Clinic Laboratories and Progentec Diagnostics collaborate on advanced biomarker testing: This strategic partnership expands access to Progentec's AI-powered blood tests for proactive management of autoimmune diseases.


Siemens Healthineers partners with Icana Care to improve early diagnosis of autoimmune diseases: This collaboration focuses on integrating Icana Care's AI-powered platform with Siemens' imaging systems for faster and more accurate diagnosis.


Roche acquires Teneobio, a French AI startup developing early-stage diagnostics for autoimmune diseases: This acquisition strengthens Roche's commitment to personalized medicine and AI-driven diagnostics.


Quest Diagnostics launches new autoimmune panels for comprehensive disease evaluation: These panels offer a streamlined approach to testing for multiple autoimmune markers in one test.


Abbott introduces a new point-of-care test for rheumatoid arthritis (RA): This rapid test allows for on-site diagnosis and faster treatment initiation.


TheraTech Technologies receives FDA approval for its anti-phospholipid syndrome (APS) diagnostic test: This approval provides a new tool for diagnosing this often-misunderstood autoimmune condition.


List of Autoimmune Disease Diagnostics companies in the market:



  • Siemens Healthcare Private Limited

  • bioMérieux SA

  • Bio-rad Laboratories

  • Beckman Coulter

  • AstraZeneca

  • EUROIMMUN AG

  • Hoffmann-la Roche

  • Inova Diagnostics

  • Myriad Genetics

  • Thermo Fisher Scientific

  • Trinity Biotech Plc.


Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.